This was reported by the press service of the ministry.

"Version 8.1 of the document describes the use of antiviral drugs with the international non-proprietary name" favipiravir "on an outpatient basis," the message says.

The Ministry of Health explained that this decision is related to the introduction of appropriate changes in the registration certificates of favipiravir drugs.

In mid-September, the Ministry of Health authorized the outpatient use of two favipiravir drugs for the treatment of patients with coronavirus infection.

In addition, it was reported that favipiravir will be included in the list of essential drugs.